GSKH Performance — GSK plc ADRhedged

Data updated: 2026-08-21

GSKH returned +9.72% year to date and +44.22% over one year to Jun 2026. Over one year the fund beat its Europe Health Care Equity category average: $100 grew to $144, against $125 for the category. Volatility over the past 12 months was 24.12% a year. In the 12 months to Jun 2026 the fund took in a net $0, and assets reached $737K.

GSKH Growth of $100

What $100 invested in GSK plc ADRhedged grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Europe Health Care Equity category average over the same months.

PeriodGSKHCategory average
1 year (Jul 2025 – Jun 2026)$144$125
Since data start (Jan 2025 – Jun 2026)$152$115

GSKH Trailing Returns

Total returns to Jun 2026, from SEC N-PORT.

PeriodTotal return
YTD+9.72%
1 year+44.22%

GSKH Annual Returns

Calendar-year total returns of GSK plc ADRhedged, compounded from monthly SEC N-PORT returns. Partial years show the months covered.

YearTotal return
2026 (Jan–Jun)+9.72%
2025+38.34%

GSKH Monthly Returns

Monthly total returns as reported on SEC Form N-PORT.

YearJanFebMarAprMayJunJulAugSepOctNovDec
2026+3.2%+17.6%−4.7%−8.0%−1.8%+5.1%——————
2025+4.5%+6.2%+0.5%−0.4%+3.0%−7.9%+0.2%+5.6%+9.0%+10.7%+2.0%+0.9%

GSKH Risk

Risk measures from monthly returns over Jul 2025 – Jun 2026.

  • 1-year volatility (annualised): 24.12%
  • Best month: +17.56% (Feb 2026)
  • Worst month: −7.98% (Apr 2026)

GSKH Fund Flows

Monthly money in and out of GSK plc ADRhedged, from SEC Form N-PORT.

  • 12-month net flow: $0
  • 12-month gross sales (incl. reinvestments): $0
MonthSalesRedemptionsNet flow
Jun 2026$0$0$0
May 2026$0$0$0
Apr 2026$0$0$0
Mar 2026$0$0$0
Feb 2026$0$0$0
Jan 2026$0$0$0
Dec 2025$0$0$0
Nov 2025$0$0$0
Oct 2025$0$0$0
Sep 2025$0$0$0
Aug 2025$0$0$0
Jul 2025$0$0$0

GSKH Assets Under Management

Net assets of GSK plc ADRhedged by report date, from SEC N-PORT filings.

Report dateNet assets
2026-06-30$737.44K
2026-03-31$786.46K
2025-12-31$683.90K
2025-09-30$607.36K
2025-06-30$526.34K
2025-03-31$1.67M

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.